Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats

Gastroenterology

Volumn 151, Issue 5, 2016, Pages 923-932

  Sato, Hirokazu ^a,b   Zhang, Linda S ^a   Martinez, Kristina ^c   Chang, Eugene B ^c   Yang, Qing ^a   Wang, Fei ^a   Howles, Philip N ^a   Hokari, Ryota ^b   Miura, Soichiro ^b   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

APOA I; APOA IV; Digestion; Microbe

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; CHYLOMICRON; DRINKING WATER; INTRALIPID; MAST CELL PROTEINASE II; PENICILLIN DERIVATIVE; PHOSPHOLIPID; PROTEINASE; STREPTOMYCIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; FAT INTAKE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DIGESTION; DRUG EFFECT; ENZYME ACTIVITY; FAT INTAKE; INTESTINAL TISSUE; INTESTINE CELL; INTESTINE FLORA; INTESTINE MOTILITY; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; LIPID ABSORPTION; LIPID HYDROLYSIS; LIPID TRANSPORT; LYMPHATIC SYSTEM; MALE; MAST CELL; MUCOSAL MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; INTESTINE ABSORPTION; METABOLISM; MICROBIOLOGY; PERMEABILITY; PHYSIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; DIETARY FATS; GASTROINTESTINAL MICROBIOME; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALE; MAST CELLS; PENICILLINS; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; STREPTOMYCIN;

EID: 84994852227     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.07.009     Document Type: Article

References (66)

1. 1 Savage, D.C., Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31 (1977), 107–133.
2. 2 Forbes, E.E., Groschwitz, K., Abonia, J.P., et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 205 (2008), 897–913.
3. 3 O'Sullivan, M., Clayton, N., Breslin, N.P., et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 12 (2000), 449–457.
4. 4 Farhadi, A., Fields, J.Z., Keshavarzian, A., Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol 13 (2007), 3027–3030.
5. 5 Garrett, W.S., Gordon, J.I., Glimcher, L.H., Homeostasis and inflammation in the intestine. Cell 140 (2010), 859–870.
6. 6 Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9 (2009), 313–323.
7. 7 Cani, P.D., Bibiloni, R., Knauf, C., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
8. 8 Lam, Y.Y., Ha, C.W., Campbell, C.R., et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One, 7, 2012, e34233.
9. 9 Ji, Y., Sakata, Y., Yang, Q., et al. Activation of rat intestinal mucosal mast cells by fat absorption. Am J Physiol Gastrointest Liver Physiol 302 (2012), G1292–G1300.
10. 10 Maintz, L., Novak, N., Histamine and histamine intolerance. Am J Clin Nutr 85 (2007), 1185–1196.
11. 11 Erridge, C., Attina, T., Spickett, C.M., et al. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86 (2007), 1286–1292.
12. 12 Ghoshal, S., Witta, J., Zhong, J., et al. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50 (2009), 90–97.
13. 13 Brenner, S.A., Zacheja, S., Schaffer, M., et al. Soluble CD14 is essential for lipopolysaccharide-dependent activation of human intestinal mast cells from macroscopically normal as well as Crohn's disease tissue. Immunology 143 (2014), 174–183.
14. 14 Kramer, S., Sellge, G., Lorentz, A., et al. Selective activation of human intestinal mast cells by Escherichia coli hemolysin. J Immunol 181 (2008), 1438–1445.
15. 15 Guo, W., Magnotti, L.J., Ding, J., et al. Influence of gut microflora on mesenteric lymph cytokine production in rats with hemorrhagic shock. J Trauma 52 (2002), 1178–1185 disciussion 1185.
16. 16 Lu, W.J., Yang, Q., Sun, W., et al. Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose. Am J Physiol Gastrointest Liver Physiol, 294, 2008 G1130–G118.
17. 17 Bollman, J.L., Cain, J.C., Grindlay, J.H., Techniques for the collection of lymph from the liver, small intestine, or thoracic duct of the rat. J Lab Clin Med 33 (1948), 1349–1352.
18. 18 Forget, P., Grandfils, C., van Cutsem, J.L., et al. Diamine oxidase and disaccharidase activities in small intestinal biopsies of children. Pediatr Res 18 (1984), 647–649.
19. 19 Wang, Q., Fang, C.H., Hasselgren, P.O., Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281 (2001), R1013–R1023.
20. 20 Joly Condette, C., Khorsi-Cauet, H., Morliere, P., et al. Increased gut permeability and bacterial translocation after chronic chlorpyrifos exposure in rats. PLoS One, 9, 2014, e102217.
21. 21 Hayashi, H., Nutting, D.F., Fujimoto, K., et al. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J Lipid Res 31 (1990), 1613–1625.
22. 22 Wang, Y., Hoenig, J.D., Malin, K.J., et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 3 (2009), 944–954.
23. 23 Vital, M., Penton, C.R., Wang, Q., et al. A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome, 1, 2013, 8.
24. 24 Louis, P., Young, P., Holtrop, G., et al. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 12 (2010), 304–314.
25. 25 Caporaso, J.G., Kuczynski, J., Stombaugh, J., et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7 (2010), 335–336.
26. 26 McDonald, D., Price, M.N., Goodrich, J., et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 6 (2012), 610–618.
27. 27 Wang, Q., Garrity, G.M., Tiedje, J.M., et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73 (2007), 5261–5267.
28. 28 Price, M.N., Dehal, P.S., Arkin, A.P., FastTree 2—approximately maximum-likelihood trees for large alignments. PLoS One, 5, 2010, e9490.
29. 29 Gibson, S., Mackeller, A., Newlands, G.F., et al. Phenotypic expression of mast cell granule proteinases. Distribution of mast cell proteinases I and II in the rat digestive system. Immunology 62 (1987), 621–627.
30. 30 Ji, Y., Sakata, Y., Li, X., et al. Lymphatic diamine oxidase secretion stimulated by fat absorption is linked with histamine release. Am J Physiol Gastrointest Liver Physiol 304 (2013), G732–G740.
31. 31 Schwelberger, H.G., Hittmair, A., Kohlwein, S.D., Analysis of tissue and subcellular localization of mammalian diamine oxidase by confocal laser scanning fluorescence microscopy. Inflamm Res 47:Suppl 1 (1998), S60–S61.
32. 32 Schayer, R.W., Kennedy, J., Smiley, R.L., Studies on histamine-metabolizing enzymes in intact animals. II. J Biol Chem 205 (1953), 739–748.
33. 33 Scudamore, C.L., Thornton, E.M., McMillan, L., et al. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med 182 (1995), 1871–1881.
34. 34 Scudamore, C.L., Jepson, M.A., Hirst, B.H., et al. The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin. Eur J Cell Biol 75 (1998), 321–330.
35. 35 Karpe, F., Hamsten, A., Uffelman, K., et al. Apolipoprotein B-48. Methods Enzymol 263 (1996), 95–104.
36. 36 Abrams, G.D., Bishop, J.E., Effect of the normal microbial flora on gastrointestinal motility. Proc Soc Exp Biol Med 126 (1967), 301–304.
37. 37 Gustafsson, B.E., Midtvedt, T., Strandberg, K., Effects of microbial contamination on the cecum enlargement of germfree rats. Scand J Gastroenterol 5 (1970), 309–314.
38. 38 Muller, P.A., Koscso, B., Rajani, G.M., et al. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell 158 (2014), 300–313.
39. 39 Frazer, A.C., Sammons, H.G., The formation of mono- and di-glycerides during the hydrolysis of triglyceride by pancreatic lipase. Biochem J 39 (1945), 122–128.
40. 40 Wang, F., Yang, Q., Huesman, S., et al. The role of apolipoprotein A-IV in regulating glucagon-like peptide-1 secretion. Am J Physiol Gastrointest Liver Physiol 309 (2015), G680–G687.
41. 41 Kohan, A.B., Howles, P.N., Tso, P., Methods for studying rodent intestinal lipoprotein production and metabolism. Curr Protoc Mouse Biol 2 (2012), 219–230.
42. 42 D'Alessio, D., Lu, W., Sun, W., et al. Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system. Am J Physiol Regul Integr Comp Physiol 293 (2007), R2163–R2169.
43. 43 Redgrave, T.G., Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest 49 (1970), 465–471.
44. 44 Bischoff, S.C., Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 31 (2009), 185–205.
45. 45 Kraneveld, A.D., Sagar, S., Garssen, J., et al. The two faces of mast cells in food allergy and allergic asthma: the possible concept of Yin Yang. Biochim Biophys Acta 1822 (2012), 93–99.
46. 46 Sher, A., McIntyre, S.L., Receptors for C3 on rat peritoneal mast cells. J Immunol 119 (1977), 722–725.
47. 47 Sher, A., Hein, A., Moser, G., et al. Complement receptors promote the phagocytosis of bacteria by rat peritoneal mast cells. Lab Invest 41 (1979), 490–499.
48. 48 Malaviya, R., Gao, Z., Thankavel, K., et al. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci U S A 96 (1999), 8110–8115.
49. 49 Supajatura, V., Ushio, H., Nakao, A., et al. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 167 (2001), 2250–2256.
50. 50 McCurdy, J.D., Lin, T.J., Marshall, J.S., Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70 (2001), 977–984.
51. 51 Supajatura, V., Ushio, H., Nakao, A., et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 109 (2002), 1351–1359.
52. 52 Demaude, J., Salvador-Cartier, C., Fioramonti, J., et al. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut 55 (2006), 655–661.
53. 53 Ferrier, L., Berard, F., Debrauwer, L., et al. Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol 168 (2006), 1148–1154.
54. 54 Jacob, C., Yang, P.C., Darmoul, D., et al. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 280 (2005), 31936–31948.
55. 55 McDermott, J.R., Bartram, R.E., Knight, P.A., et al. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci U S A 100 (2003), 7761–7766.
56. 56 Soderholm, J.D., Yang, P.C., Ceponis, P., et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 123 (2002), 1099–1108.
57. 57 Bischoff, S.C., Kramer, S., Human mast cells, bacteria, and intestinal immunity. Immunol Rev 217 (2007), 329–337.
58. 58 van Diest, S.A., Stanisor, O.I., Boeckxstaens, G.E., et al. Relevance of mast cell-nerve interactions in intestinal nociception. Biochim Biophys Acta 1822 (2012), 74–84.
59. 59 Cani, P.D., Possemiers, S., Van de Wiele, T., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (2009), 1091–1103.
60. 60 Moreira, A.P., Texeira, T.F., Ferreira, A.B., et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108 (2012), 801–809.
61. 61 Kirpich, I.A., Feng, W., Wang, Y., et al. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcohol Clin Exp Res 36 (2012), 835–846.
62. 62 Hou, J.K., Abraham, B., El-Serag, H., Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106 (2011), 563–573.
63. 63 Amar, J., Burcelin, R., Ruidavets, J.B., et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 87 (2008), 1219–1223.
64. 64 Albers, J.J., Kennedy, H., Marcovina, S.M., Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: evaluation of amino acid analysis data. J Lipid Res 37 (1996), 192–196.
65. 65 Weinberg, R.B., Gallagher, J.W., Fabritius, M.A., et al. ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins. J Lipid Res 53 (2012), 736–743.
66. 66 Velagapudi, V.R., Hezaveh, R., Reigstad, C.S., et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 51 (2010), 1101–1112.